Product Information
FT IBUPROFEN 200 MG CAPLET is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0329 per EA under NDC 70677113603. Its NADAC has been published 138 times since Jan 3, 2024.
FDA first approved this application on Dec 8, 1987.
The High Outlier badge above means this manufacturer's average price in the Ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
200 mg/1
Manufacturer
Strategic Sourcing Services LLCNDC
70677113603
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA072096FDA Approved
12/8/1987
On Market Since
10/20/2023
Pharmacological Classes
Price Statistics
The NADAC for FT IBUPROFEN 200 MG CAPLET has been published 138 times since Jan 3, 2024, and over the history we have for it it has risen 4.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0329 per EA |
|---|---|
| All-time high | $0.0370 (Nov 12, 2025) |
| All-time low | $0.0300 (Apr 17, 2024) |
| 52-week high | $0.0370 |
| 52-week low | $0.0320 |
| Median price | $0.0329 |
| Average price | $0.0336 |
| Largest weekly change | -13.7% (Apr 17, 2024) |
| Weeks tracked | 138 |
| Tracking since | Jan 3, 2024 |
Generic Alternatives
The matcher finds 9 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 18% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of FT IBUPROFEN 200 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for FT IBUPROFEN 200 MG CAPLET, manufactured by Strategic Sourcing Services LLC, is $0.0329 per EA (NDC 70677113603), effective Aug 19, 2026.
How has the price of FT IBUPROFEN 200 MG CAPLET changed over time?
Over the history we have for it, the NADAC for FT IBUPROFEN 200 MG CAPLET has risen 4.3%. It has been tracked across 138 weekly CMS publications since Jan 3, 2024.
What are the highest and lowest recorded NADAC prices for FT IBUPROFEN 200 MG CAPLET?
Since Jan 3, 2024, the NADAC for FT IBUPROFEN 200 MG CAPLET has ranged from a low of $0.0300 (Apr 17, 2024) to a high of $0.0370 (Nov 12, 2025), with a median of $0.0329 per EA.
Are there cheaper alternatives to FT IBUPROFEN 200 MG CAPLET?
Yes. 9 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 200 MG TABLET, is $0.0269 per EA — about 18% below FT IBUPROFEN 200 MG CAPLET.
Who manufactures FT IBUPROFEN 200 MG CAPLET?
FT IBUPROFEN 200 MG CAPLET (NDC 70677113603) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.